You have 9 free searches left this month | for more free features.

abt-263

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia Trial in Worldwide (ABT-263)

Completed
  • Chronic Lymphocytic Leukemia
  • ABT-263
  • La Jolla, California
  • +9 more
Jul 8, 2022

Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma Trial in Canada, United States (ABT-263)

Completed
  • Chronic Lymphoid Leukemia
  • +5 more
  • ABT-263
  • Los Angeles, California
  • +11 more
Jul 28, 2021

Platinum-resistant or Refractory Ovarian Cancer Trial in France (ABT-263)

Completed
  • Platinum-resistant or Refractory Ovarian Cancer
  • ABT-263
  • Besançon, France
  • +15 more
Mar 15, 2019

Solid Tumors Trial in United States (ABT-263, etoposide/cisplatin)

Completed
  • Solid Tumors
  • Chicago, Illinois
  • +6 more
Jun 1, 2018

Small Cell Lung Cancer, Small Cell Lung Carcinoma Trial in Canada, United Kingdom, United States (ABT-263)

Completed
  • Small Cell Lung Cancer
  • Small Cell Lung Carcinoma
  • ABT-263
  • Peoria, Arizona
  • +17 more
Jun 1, 2018

Lymphoid Malignancy, Solid Tumors Trial (ABT-263)

Completed
  • Lymphoid Malignancy
  • Solid Tumors
  • ABT-263
  • (no location specified)
Nov 17, 2017

Solid Tumors Trial in United States (ABT-263, erlotinib, irinotecan (3-week schedule))

Completed
  • Solid Tumors
  • ABT-263
  • +3 more
  • Santa Monica, California
  • +3 more
Nov 16, 2017

Solid Tumors Trial (ABT-263, paclitaxel)

Completed
  • Solid Tumors
  • (no location specified)
Nov 17, 2017

Solid Tumors Trial (ABT-263, gemcitabine)

Completed
  • Solid Tumors
  • (no location specified)
Nov 17, 2017

Prostate Cancer Trial in New Brunswick (Abiraterone, ABT-263, Hydroxychloroquine)

Terminated
  • Prostate Cancer
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Mar 30, 2017

Chronic Lymphocytic Leukemia Trial in Worldwide (ABT-263, rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • Alhambra, California
  • +102 more
Nov 1, 2016

Chronic Lymphocytic Leukemia Trial in United States (ABT-263, FCR, BR)

Completed
  • Chronic Lymphocytic Leukemia
  • ABT-263
  • +2 more
  • La Jolla, California
  • +5 more
Jun 5, 2013

Solid Tumor Trial in Netherlands, United Kingdom, United States (ABT-263, Docetaxel)

Completed
  • Solid Tumor
  • Scottsdale, Arizona
  • +5 more
May 18, 2012

Lymphoma, Chronic Lymphocytic Leukemia, Solid Tumors Trial in San Antonio (ABT-263, Ketoconazole)

Completed
  • Lymphoma
  • +2 more
  • San Antonio, Texas
    Site Reference ID/Investigator# 25068
Dec 16, 2010

Healthy Female Subjects Trial in Waukegan (ABT-263)

Completed
  • Healthy Female Subjects
  • ABT-263
  • Waukegan, Illinois
    Site Reference ID/Investigator# 23602
Nov 8, 2010

Chronic Lymphocytic Leukemia, Lymphomas, Leukemias Trial in United States (ABT-263)

Completed
  • Chronic Lymphocytic Leukemia
  • +2 more
  • ABT-263
  • Encinitas, California
  • +4 more
Oct 6, 2010

B-cell Chronic Lymphocytic Leukemia Trial (ABT-263)

Withdrawn
  • B-cell Chronic Lymphocytic Leukemia
  • ABT-263
  • (no location specified)
Feb 25, 2010